Glimanthro-MV 1 Tablet
Manufacturer
Silantro Pharma Private Limited
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Key Information
Short Description
Glimanthro-MV 1 Tablet is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Dosage Form
Tablet
Introduction
Glimanthro-MV 1 Tablet is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimanthro-MV 1 Tablet is to be taken empty stomach.
Safety Information
Side Effects
No common side effects listed.
Alcohol Warning
It is unsafe to consume alcohol with Glimanthro-MV 1 Tablet.
Breastfeeding Warning
Glimanthro-MV 1 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Pregnancy Warning
Glimanthro-MV 1 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Glimanthro-MV 1 Tablet is a combination of three antidiabetic medicines:
Quick Tips
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Related Medicines
Ozomet VG 1mg/500mg/0.2mg Tablet
M Pride V 1/0.2mg Tablet
Glucowave MV 1mg/500mg/0.2mg Tablet
Volpost GM 1mg/500mg/0.2mg Tablet
Volibose Trio 1mg/500mg/0.2mg Tablet
Metgli V 1 mg/500 mg/0.2 mg Tablet
Diatune-VG 1mg/500mg/0.2mg Tablet
Voglivil 1mg/500mg/0.2mg Tablet
Vogliaid GM 1mg/500mg/0.2mg Tablet
Gmvlot 1mg/500mg/0.2mg Tablet
Frequently asked questions
What is Glimanthro-MV 1 Tablet?
Glimanthro-MV 1 Tablet is a combination medication consisting of Glimepiride, Metformin, and Voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, helping to improve blood glucose levels when taken along with a proper diet and regular exercise.
What are the possible side effects of Glimanthro-MV 1 Tablet?
Common side effects associated with the use of Glimanthro-MV 1 Tablet include hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection.
Are there any specific conditions in which Glimanthro-MV 1 Tablet should not be taken?
The use of Glimanthro-MV 1 Tablet is contraindicated in patients with a known allergy to any component or excipient, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis including diabetic ketoacidosis.
Is it safe to take alcohol while I am also taking Glimanthro-MV 1 Tablet?
No, it is not recommended to consume alcohol while taking Glimanthro-MV 1 Tablet, as it may lower blood sugar levels and increase the risk of lactic acidosis.
Can the use of Glimanthro-MV 1 Tablet cause hypoglycemia?
Yes, the use of Glimanthro-MV 1 Tablet can lead to hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. Regular monitoring of blood sugar levels is essential, especially if you miss or delay meals, consume alcohol, over-exercise, or take other antidiabetic medications.
What are the instructions for the storage and disposal of Glimanthro-MV 1 Tablet?
Store Glimanthro-MV 1 Tablet in its original packet or container, tightly closed. Dispose of unused medication properly, ensuring it is not consumed by pets, children, or other individuals.
